在国家卫生系统内实施辅助生殖技术的经济效益:来自意大利模式的见解。

IF 3.3 3区 经济学 Q1 ECONOMICS
Andrea Marcellusi, Matteo Scortichini, Giulio Guarnotta, Mark Connolly, Andrea Busnelli
{"title":"在国家卫生系统内实施辅助生殖技术的经济效益:来自意大利模式的见解。","authors":"Andrea Marcellusi, Matteo Scortichini, Giulio Guarnotta, Mark Connolly, Andrea Busnelli","doi":"10.1186/s13561-025-00672-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Models evaluating both costs and economic benefits of assisted reproductive technology (ART) implementation are lacking. This constitutes a major limitation in the decision-making process of resource allocation. Herein, we aimed to estimate the economic and social impact of female infertility in Italy and examine the benefits generated by investment in ART from a national perspective.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted using the Italian Hospital Discharge Records database to identify women aged 18-50 undergoing ART between 2014 and 2016 in Italy. Patients were followed for up to 36 months after the first ART complete cycle. Hospitalization costs were analyzed nationally, while outpatient care and drug consumption costs were assessed in a sub-analysis using administrative databases from LHU Umbria 2. A fiscal impact model was developed from a governmental perspective, projecting lifetime tax revenues and public expenditures associated with the ART birth cohort, including costs for healthcare, education, pensions, and social transfers. All future values were discounted at 3% in line with Italian economic evaluation guidelines.</p><p><strong>Results: </strong>A total of 33,713 women met the inclusion criteria. During the follow-up, 48.4% achieved pregnancy resulting in childbirth. The average hospital care cost per patient was €5,853, with a projected national expenditure of €337 million for ART management. Younger women (18-33 years) had the highest success rates (61.8%). Assuming 16,300 live births, the model estimated net fiscal benefits of €3.3 billion over the lifetime of these individuals, equivalent to €203,856 per live birth.</p><p><strong>Conclusion: </strong>This study highlights the economic and fiscal benefits of ART, emphasizing the need for policies promoting early access to treatment. ART investment represents a strategic approach to mitigate demographic decline, with each live birth substantially contributing to national fiscal stability.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"76"},"PeriodicalIF":3.3000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12487317/pdf/","citationCount":"0","resultStr":"{\"title\":\"The economic benefit of implementing assisted reproductive technology within a national health system: insights from the Italian model.\",\"authors\":\"Andrea Marcellusi, Matteo Scortichini, Giulio Guarnotta, Mark Connolly, Andrea Busnelli\",\"doi\":\"10.1186/s13561-025-00672-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Models evaluating both costs and economic benefits of assisted reproductive technology (ART) implementation are lacking. This constitutes a major limitation in the decision-making process of resource allocation. Herein, we aimed to estimate the economic and social impact of female infertility in Italy and examine the benefits generated by investment in ART from a national perspective.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted using the Italian Hospital Discharge Records database to identify women aged 18-50 undergoing ART between 2014 and 2016 in Italy. Patients were followed for up to 36 months after the first ART complete cycle. Hospitalization costs were analyzed nationally, while outpatient care and drug consumption costs were assessed in a sub-analysis using administrative databases from LHU Umbria 2. A fiscal impact model was developed from a governmental perspective, projecting lifetime tax revenues and public expenditures associated with the ART birth cohort, including costs for healthcare, education, pensions, and social transfers. All future values were discounted at 3% in line with Italian economic evaluation guidelines.</p><p><strong>Results: </strong>A total of 33,713 women met the inclusion criteria. During the follow-up, 48.4% achieved pregnancy resulting in childbirth. The average hospital care cost per patient was €5,853, with a projected national expenditure of €337 million for ART management. Younger women (18-33 years) had the highest success rates (61.8%). Assuming 16,300 live births, the model estimated net fiscal benefits of €3.3 billion over the lifetime of these individuals, equivalent to €203,856 per live birth.</p><p><strong>Conclusion: </strong>This study highlights the economic and fiscal benefits of ART, emphasizing the need for policies promoting early access to treatment. ART investment represents a strategic approach to mitigate demographic decline, with each live birth substantially contributing to national fiscal stability.</p>\",\"PeriodicalId\":46936,\"journal\":{\"name\":\"Health Economics Review\",\"volume\":\"15 1\",\"pages\":\"76\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12487317/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Economics Review\",\"FirstCategoryId\":\"96\",\"ListUrlMain\":\"https://doi.org/10.1186/s13561-025-00672-1\",\"RegionNum\":3,\"RegionCategory\":\"经济学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ECONOMICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Economics Review","FirstCategoryId":"96","ListUrlMain":"https://doi.org/10.1186/s13561-025-00672-1","RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0

摘要

背景:目前缺乏评估辅助生殖技术(ART)实施成本和经济效益的模型。这是资源分配决策过程中的一个主要限制。在此,我们旨在估计意大利女性不孕症的经济和社会影响,并从国家角度检查ART投资产生的收益。方法:利用意大利医院出院记录数据库进行回顾性队列研究,确定2014年至2016年在意大利接受ART治疗的18-50岁女性。患者在第一个ART完整周期后随访长达36个月。住院费用在全国范围内进行了分析,而门诊护理和药物消费费用在使用LHU Umbria 2的行政数据库的亚分析中进行了评估。从政府角度开发了一个财政影响模型,预测了与ART出生队列相关的终身税收收入和公共支出,包括医疗保健、教育、养老金和社会转移支付的成本。根据意大利经济评估指南,所有未来价值均按3%折现。结果:共有33713名女性符合纳入标准。在随访期间,48.4%的人成功怀孕并分娩。每位患者的平均住院护理费用为5,853欧元,预计国家用于抗逆转录病毒治疗管理的支出为3.37亿欧元。年轻女性(18-33岁)的成功率最高(61.8%)。假设有16,300名活产婴儿,该模型估计这些人一生的净财政收益为33亿欧元,相当于每个活产婴儿203,856欧元。结论:本研究强调了抗逆转录病毒治疗的经济和财政效益,强调需要制定促进早期获得治疗的政策。抗逆转录病毒治疗投资是缓解人口下降的一种战略办法,每一个活产都大大促进了国家财政稳定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The economic benefit of implementing assisted reproductive technology within a national health system: insights from the Italian model.

Background: Models evaluating both costs and economic benefits of assisted reproductive technology (ART) implementation are lacking. This constitutes a major limitation in the decision-making process of resource allocation. Herein, we aimed to estimate the economic and social impact of female infertility in Italy and examine the benefits generated by investment in ART from a national perspective.

Methods: A retrospective cohort study was conducted using the Italian Hospital Discharge Records database to identify women aged 18-50 undergoing ART between 2014 and 2016 in Italy. Patients were followed for up to 36 months after the first ART complete cycle. Hospitalization costs were analyzed nationally, while outpatient care and drug consumption costs were assessed in a sub-analysis using administrative databases from LHU Umbria 2. A fiscal impact model was developed from a governmental perspective, projecting lifetime tax revenues and public expenditures associated with the ART birth cohort, including costs for healthcare, education, pensions, and social transfers. All future values were discounted at 3% in line with Italian economic evaluation guidelines.

Results: A total of 33,713 women met the inclusion criteria. During the follow-up, 48.4% achieved pregnancy resulting in childbirth. The average hospital care cost per patient was €5,853, with a projected national expenditure of €337 million for ART management. Younger women (18-33 years) had the highest success rates (61.8%). Assuming 16,300 live births, the model estimated net fiscal benefits of €3.3 billion over the lifetime of these individuals, equivalent to €203,856 per live birth.

Conclusion: This study highlights the economic and fiscal benefits of ART, emphasizing the need for policies promoting early access to treatment. ART investment represents a strategic approach to mitigate demographic decline, with each live birth substantially contributing to national fiscal stability.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.90
自引率
4.20%
发文量
59
审稿时长
13 weeks
期刊介绍: Health Economics Review is an international high-quality journal covering all fields of Health Economics. A broad range of theoretical contributions, empirical studies and analyses of health policy with a health economic focus will be considered for publication. Its scope includes macro- and microeconomics of health care financing, health insurance and reimbursement as well as health economic evaluation, health services research and health policy analysis. Further research topics are the individual and institutional aspects of health care management and the growing importance of health care in developing countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信